Abstract:The overuse of antibiotics over an extended period has led to increasing antibiotic resistance in pathogenic bacteria, culminating in what is now considered a global health crisis. To tackle the escalating disaster caused by multidrug-resistant pathogens, the development of new bactericides with new action mechanism is highly necessary. In this study, using a biomimicking strategy, a series of new nonivamide derivatives that feature an isopropanolamine moiety [the structurally similar to the diffusible signal factor (DSF) of Xanthomonas spp.] were prepared for serving as potential quorum-sensing inhibitors (QSIs). After screening and investigation of their rationalizing structure-activity relationships (SARs), compound A26 was discovered as the most optimal active molecule, with EC50 values of 9.91 and 7.04 μg mL-1 against Xanthomonas oryzae pv oryzae (Xoo) and Xanthomonas axonopodis pv. citri (Xac). A docking study showed that compound A26 exhibited robust interactions with Glu A: 161 of RpfF, which was strongly evidenced by fluorescence titration assay (KA value for Xoo RpfF-A26 = 104.8709 M-1). Furthermore, various bioassays showed that compound A26 could inhibit various bacterial virulence factors, including biofilm formation, extracellular polysaccharides (EPS), extracellular enzyme activity, DSF production, and swimming motility. In addition, in vivo anti-Xoo results showed that compound A26 had excellent control efficiency (curative activity: 43.55 %; protective activity: 42.56 %), surpassing that of bismerthiazol and thiodiazole copper by approximately 8.0%-37.3 %. Overall, our findings highlight a new paradigm wherein nonivamide derivatives exhibit potential in combating pathogen resistance issues by inhibiting bacterial quorum sensing systems though attributing to their new molecular skeleton, novel mechanisms of action, and non-toxic features.

Structural insights into the inhibition of bacterial RecA by naphthalene polysulfonated compounds

Nosiheptide Analogues As Potential Antibacterial Agents Via Dehydroalanine Region Modifications: Semi-synthesis, Antimicrobial Activity and Molecular Docking Study.

Recreating the natural evolutionary trend in key microdomains provides an effective strategy for engineering of a thermomicrobial <i>N</i>-demethylase

Computational Elucidation of the Binding Mechanisms of Curcumin Analogues As Bacterial RecA Inhibitors

Structural Basis of Inhibition of the Pioneer Transcription Factor NF-Y by Suramin

Suramin and NF449 are IP5K inhibitors that disrupt inositol hexakisphosphate–mediated regulation of cullin–RING ligase and sensitize cancer cells to MLN4924/pevonedistat

Reductive Inactivation of the Hemiaminal Pharmacophore for Resistance Against Tetrahydroisoquinoline Antibiotics.

Potentiometric and Substrate Specificity Studies

Structural Basis of Escherichia Coli Nitroreductase NfsB Triple Mutants Engineered for Improved Activity and Regioselectivity Toward the Prodrug CB1954

Conformational Dynamics of the Periplasmic Chaperone SurA

Application of Cation-Π Interactions in Enzyme-Substrate Binding: Design, Synthesis, Biological Evaluation, and Molecular Dynamics Insights of Novel Hydrophilic Substrates for NQO1.

Probing the Anion Binding Promiscuity of the Soluble Nitrate Sensor NreA from Staphylococcus carnosus

Suramin Disturbs the Association of the N-Terminal Domain of SARS-CoV-2 Nucleocapsid Protein with RNA

Structure-guided optimization and mechanistic study of a class of quinazolinone-threonine hybrids as antibacterial ThrRS inhibitors

Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds

Engineering a biomimicking strategy for discovering nonivamide-based quorum-sensing inhibitors for controlling bacterial infection

New insights into the binding mechanism of lysozyme by 2-sulfanilamido-4-methylpyrimidine and 3-sulfanilamido-5-methylisoxazole: Density function theory, multispectral techniques and molecular docking

Extracellularly oxidative activation and inactivation of matured prodrug for cryptic self-resistance in naphthyridinomycin biosynthesis.

Discovery of Sortase A Covalent Inhibitors with Benzofuranene Cyanide Structures As Potential Antibacterial Agents Against Staphylococcus Aureus.

Discovery of Inhibitors Targeting Protein-Protein Interaction between Bacterial RNA Polymerase and NusG as Novel Antimicrobials

Novel Bacterial NAD + -Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy in Vivo